癌症药物的加速批准计划:庆祝超过25万个获得的生命年,并继续计算
Julie Patterson1, John Michael O'Brien, Jonathan D Campbell
1National Pharmaceutical Council, 717 Pennsylvania Ave NW, Ste 800, Washington, DC 20006.
The American journal of managed care
|August 15, 2024
概括
检查美国食品和药物管理局 (FDA) 瘤药物加速批准计划的两项研究在临床益处方面得出了不同的结论. 这篇评论分析了这些对比的发现.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
- 监管科学 监管科学
背景情况:
- 美国食品和药物管理局 (FDA) 的加速批准途径允许更早地获得新瘤学药物.
- 评估通过这种途径批准的药物的实际临床益处仍然是研究的关键领域.
- 对临床效用数据的相互矛盾的解释可能来自不同的研究设计和终点.
研究的目的:
- 分析和比较两项最近的研究的方法和结论.
- 讨论不同发现对FDA癌症治疗药物的加速批准计划的影响.
- 突出未来对药物益处的评估的主要考虑因素.
主要方法:
- 两项已发表的研究的比较分析.
- 对研究设计,患者群体和结果措施的审查.
- 关于临床益处的不同解释的综合.
主要成果:
- 研究A得出结论,加速批准计划在特定瘤学适应症方面显示出显著的临床益处.
- 研究B对该计划批准的药物的整体临床实用性和市场后证据生成提出了担忧.
- 差异归因于统计方法的变化和临床益处的定义.
结论:
- 不同的结论强调了通过加速途径评估药物疗效的复杂性.
- 需要使用标准化方法进行进一步的研究,以确定FDA加速性瘤药物的临床益处.
- 协调评估框架对于一致的监管决策和改善患者结果至关重要.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
